Dry Age Related Macular Degeneration Market Report: Trends, Forecast and Competitive Analysis to 2030

Dry Age Related Macular Degeneration Trends and Forecast

The future of the global dry age related macular degeneration market looks promising with opportunities in the hospitals & clinics, diagnostic centers, and academic & research institutes markets. The global dry age related macular degeneration market is expected to grow with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are rising elderly populations and growing incidence of age-related macular degeneration.

A more than 150-page report is developed to help in your business decisions.

Dry Age Related Macular Degeneration by Segment

The study includes a forecast for the global dry age related macular degeneration by age group, diagnosis & treatment, route of administration, end use industry, and region.

Dry Age Related Macular Degeneration Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

• Above 75 Years
• Above 60 Years
• Above 40 Years

Dry Age Related Macular Degeneration Market by Diagnosis & Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Treatment
• Diagnosis

Dry Age Related Macular Degeneration Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Oral
• Injectables

Dry Age Related Macular Degeneration Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Diagnostic Centers
• Academic & Research Institutes
• Others

Dry Age Related Macular Degeneration Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Dry Age Related Macular Degeneration Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dry age related macular degeneration companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dry age related macular degeneration companies profiled in this report include-

• Santen Pharmaceuticals
• Allergan
• Bausch Health
• Alimera Science
• Phio Pharmaceuticals
• Ocumension Therapeutics
• Belite Bio
• Kubota Vision
• Iveric Bio
• Eyestem Research

Dry Age Related Macular Degeneration Market Insights

Lucintel forecasts that above 75 years is expected to witness largest growth over the forecast period due to rising population of senior patients.

Within this market, hospitals & clinics will remain the largest segment due to the installation of advanced and comprehensive treatment facilities in hospitals.

North America is expected to witness highest growth over the forecast period due to government initiatives and financial support are further driving the expansion of this market in this region.

Features of the Global Dry Age Related Macular Degeneration Market

Market Size Estimates: Dry age related macular degeneration market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Dry age related macular degeneration market size by various segments, such as by age group, diagnosis & treatment, route of administration, end use industry, and region in terms of value ($B).

Regional Analysis: Dry age related macular degeneration market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different age group, diagnosis & treatment, route of administration, end use industry, and regions for the dry age related macular degeneration market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dry age related macular degeneration market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for dry age related macular degeneration market?

Answer: The global dry age related macular degeneration market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the dry age related macular degeneration market?

Answer: The major drivers for this market are rising elderly populations and growing incidence of age-related macular degeneration.

Q3. What are the major segments for dry age related macular degeneration market?

Answer: The future of the dry age related macular degeneration market looks promising with opportunities in the hospitals & clinics, diagnostic centers, and academic & research institutes markets.

Q4. Who are the key dry age related macular degeneration market companies?

Answer: Some of the key dry age related macular degeneration companies are as follows.

• Santen Pharmaceuticals
• Allergan
• Bausch Health
• Alimera Science
• Phio Pharmaceuticals
• Ocumension Therapeutics
• Belite Bio
• Kubota Vision
• Iveric Bio
• Eyestem Research

Q5. Which dry age related macular degeneration market segment will be the largest in future?

Answer: Lucintel forecasts that above 75 years is expected to witness largest growth over the forecast period due to rising population of senior patients.

Q6. In dry age related macular degeneration market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to government initiatives and financial support are further driving the expansion of this market in this region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the dry age related macular degeneration market by age group (above 75 years, above 60 years, and above 40 years), diagnosis & treatment (treatment and diagnosis), route of administration (oral and injectables), end use industry (hospitals & clinics, diagnostic centers, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?